Détails sur le projet
Description
Essential hypertension in man and the genetically-determined hypertension
of the Spontaneously Hypertensive Rat (Okamoto-Aoki strain) share many
similarities, and the rat disorder is considered a useful model of the
human disease. Calcium abnormalities occur in both syndromes, and many
studies point to a plasma membrane defect involving decreased membrane
binding of Ca and increased cytosolic Ca. In arterial smooth muscle cells
this could result in increased tonus and peripheral resistance. Our
laboratory has recently isolated an integral membrane calcium binding
protein, IMCAL, which is widely distributed in rat tissues, dependent on
vitamin D and dietary Ca, and highly correlated with Ca translocation in
rat intestine. Immunochemical assays with monoclonal and polyclonal
antibodies have demonstrated decreased content of IMCAL in tissues of SHR
as compared to Wistar-Kyoto (WKy) controls. Accordingly, this research
will test the hypothesis that the genetic defect in SHR which results in
hypertension does so by decreasing membrane IMCAL. Tissues of suckling and
weanling SHR and WKy will be assayed for IMCAL to establish whether the
membrane change precedes the hypertension. IMCAL content of the tissues in
other rat models of hypertension (Goldblatt 2 kidney/1 clip and DOCA-saline
treatment) will be estimated. Regulation of tissue IMCAL in vivo by
vitamin D and dietary Ca will be compared in SHR and WKy. IMCAL content of
the mesenteric arterial wall and of primary cultures of smooth muscle cells
derived from the arterial wall of SHR and WKy will be quantified. The
possibility of regulation of the IMCAL content in cell cultures by ambient
Ca or 1,25-dihydroxyvitamin D3 will be explored. Finally, a pilot project
will compare the IMCAL content of the erythrocyte membrane of essential
hypertension patients with those of matched controls. The studies will
provide new information on the molecular basis of calcium homeostasis and
hypertension in SHR and may lead to a biological marker of essential
hypertension in man.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 9/1/86 → 1/1/90 |
Financement
- National Heart, Lung, and Blood Institute
Keywords
- Inmunología
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.